Open access
Sep 2026
Multi-omics and experimental validation reveal ISG20L2 as a potential pro-oncogenic regulator in gastric cancer
ISG20L2 is aberrantly upregulated and associated with malignant biological features and immune-related characteristics in gastric cancer, supporting its potential role as a pro-oncogenic regulator and a candidate molecular indicator requiring further clinical validation.
Song Liang, Chuan-Jun Wang, Yong-Kang Liang et al.
· Frontiers in Oncology · 0 citations